{"id":"NCT01475071","sponsor":"Galderma R&D","briefTitle":"Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses","officialTitle":"Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-03","primaryCompletion":"2012-11","completion":"2013-03","firstPosted":"2011-11-21","resultsPosted":"2016-04-18","lastUpdate":"2021-02-18"},"enrollment":100,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratoses"],"interventions":[{"type":"DRUG","name":"Metvix and natural daylight PDT","otherNames":[]},{"type":"DRUG","name":"Metvix and conventional PDT","otherNames":[]}],"arms":[{"label":"Metvix and daylight","type":"EXPERIMENTAL"},{"label":"Metvix and lamp","type":"ACTIVE_COMPARATOR"}],"summary":"The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy with Aktilite™ lamp in subjects with mild actinic keratoses (intra-individual comparison).","primaryOutcome":{"measure":"Lesion Response","timeFrame":"Week12","effectByArm":[{"arm":"Metvix and Daylight","deltaMin":89.2,"sd":15},{"arm":"Metvix and Lamp","deltaMin":92.8,"sd":14.1}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0345"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":6,"countries":["Australia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":100},"commonTop":["skin reaction","scab","photosensitivity reaction","squamous cell carcinoma","pain of skin"]}}